Nouvelle déclaration d'incident
No de la demande: 2023-0158
Numéro de référence du titulaire d'homologation: 3464251
Nom du titulaire (nom légal complet, aucune abbréviation): Bayer CropScience Inc.
Adresse: 160 Quarry Park Boulevard SE Suite 130
Ville: CALGARY
État: AB
Pays: Canada
Code postal /Zip: T2C 3G3
Incident chez l'humain
Pays: UNITED STATES
État: GEORGIA
Inconnu
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. Inconnu
Nom du produit: Roundup Weed & Grass Killer RTU
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. Inconnu
Nom du produit: Round Up 365
Liquide
Oui
Inconnu
Site: Res. - Out Home / Rés - à l'ext.maison
Inconnu
Personne affectée
Sexe: Femme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
Unknown / Inconnu
Oui
Oui
Inconnu
Non professionnel
Application
Quelle était l'activité? Please refer to field 13 on Subform II or field 17 of subform III for a detailed description regarding the activity
Aucun
Respiratoire
Unknown / Inconnu
<=30 min / <=30 min
12/15/2022 Caller is calling to report hospitalization in relation to the RoundUp Weed Grass Killer Ready To Use, but cannot confirm thats what was used. She reports applying the product as directed about a year ago, around November 2021. 15 minutes after applying she began having a coughing and breathing heavily. She went to the emergency room and was given an oral steroid and nebulizer treatments. She has been to emergency room multiple times since. She went to her primary doctor around July 2022 and was diagnosed with Hypersensitivity Pneumonitis. He prescribed a steroid shot and albuterol inhaler. On November 26th, 2022 she was found passed out on the floor by her daughter and was hospitalized the same day. They ran intravenous antibiotics and she was diagnosed with acute respiratory failure. Her discharge paperwork says doctors were unsure if she was having effects related to hypoxia, hypercapnia, influenza, multifocal pneumonitis, or sepsis from an unspecified organism. She was discharged home on December 2nd, 2022 on continuous 3 liters oxygen, oxycodone, azithromycin, benzonatate, cefdinir, fluticasone, furosemide, and potassium and referred to a pulmonologist. She has not been able to find a pulmonologist who takes her insurance. She continues to use oxygen and is taking medication as prescribed. 12/19/2022 Callback from consumer. She reports the product name now as RoundUp 365, a new date of initial hospitalization of November 27th, 2022 instead of the 26th, new date of product use around December 2021. additional prescription of Xanax, albuterol treatments and an inhaler, and an additional diagnoses of Respiratory Failure, Hypercapria Influenza A , Multifocal Pneumonitis and was told the lining of her lungs were damaged by chemicals. echocardiogram, intravenous dye imaging, and unspecified bloodwork while in the hospital. Results of those exams are unknown.
Majeure
A temporal relationship exists between product use and the initial onset of symptoms but ongoing and worsening symptoms would not be expected when the product was used as directed with no known unintended exposure. Other differential diagnoses such as infectious diseases have not been ruled out and additionally been named as possible causes by her providers. Her symptoms have not resolved, and have worsened since initial exposure and no known additional exposure to the product has been reported.